BiltRx review

The disclosure here is done properly. Each product card carries its own approval status next to its price — the two compounded products marked not approved, the four branded ones marked approved — and each label is accurate. Most sellers put that in a footer if they make the point at all, and moving it beside the price is where it belongs, because that is where the decision happens. The price is the other headline. Compounded semaglutide at eighty-one dollars a month is the lowest monthly figure published anywhere on this site, low enough that it was read twice on separate loads and checked against the page markup before being recorded here rather than taken at face value. It is real. What is missing is what it buys. No dose sits behind either compounded figure — no milligrams, no starting strength, no ladder — so there is no way to tell from the site whether that price covers a maintenance dose or a starter quantity that climbs once you are enrolled. On a figure this far below everyone else, that is the question to put to them first.

Vs median

$88/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

BiltRx dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Two things stand out. The first is the approval labeling: each product card states whether that product is FDA-approved, and each label is correct — the compounded semaglutide and tirzepatide are marked NOT FDA APPROVED, the branded four are marked approved. Most sellers here put that disclosure in a footer if they make it at all, and putting it on the card beside the price is the honest place for it. The second is the price. Compounded semaglutide at $81 a month is the lowest figure published anywhere on this site, low enough to be worth checking twice, which is why it was read on two separate loads and confirmed against the page markup before being recorded. What the site does not do is say what that money buys. There is no dose behind either compounded figure — no milligrams, no starting strength, no ladder — so a reader cannot tell whether $81 buys a starter quantity that rises later or a rate that holds. On a price this far below the field, that is the question worth asking before ordering.

No dose sits behind either compounded price, so what the figure buys is unstated.

• A price this far below the field is worth confirming covers a maintenance dose and not just a starting one.
• No compounding pharmacy is named.

BiltRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Is compounded GLP-1 safe?
• What microdosing GLP-1 costs
• The true annual cost of a plan
• Microdose & reconstitution calculator